Editas Medicine Announces First Quarter 2018 Results and Update – GlobeNewswire (press release)
Macon Daily |
Editas Medicine Announces First Quarter 2018 Results and Update
GlobeNewswire (press release) As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 genome editing systems into a robust pipeline of treatments for people living with serious diseases around the … BeyondSpring (BYSI) vs. Editas Medicine (EDIT) Head to Head Analysis |
